The odyssee study: prevention of dysbiosis complications with autologous fecal microbiota transfer (fmt) in acute myeloid leukemia (aml) patients undergoing intensive treatment: results of a prospective multicenter trial - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Communication Dans Un Congrès Année : 2018

The odyssee study: prevention of dysbiosis complications with autologous fecal microbiota transfer (fmt) in acute myeloid leukemia (aml) patients undergoing intensive treatment: results of a prospective multicenter trial

Etienne Paubelle
Cyrielle Gasc
  • Fonction : Auteur

Dates et versions

hal-02733908 , version 1 (02-06-2020)

Identifiants

Citer

Mohamad Mohty, Florent Malard, Anne Vekhoff, Simona Lapusan, Françoise Isnard, et al.. The odyssee study: prevention of dysbiosis complications with autologous fecal microbiota transfer (fmt) in acute myeloid leukemia (aml) patients undergoing intensive treatment: results of a prospective multicenter trial. 60th Annual Meeting of the American-Society-of-Hematology (ASH), American Society of Hematology (ASH). USA., Dec 2018, San Diego, CA, United States. pp.4, ⟨10.1182/blood-2018-99-112825⟩. ⟨hal-02733908⟩
79 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More